University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), Institut Universitaire du Cancer de Toulouse, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), QIMR Berghofer Medical Research Institute - Oncology and Cellular Immunology Laboratory, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), Université Côte d’Azur - CNRS, Inserm, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, University of Toulouse 3, Paul Sabatier University - Physiopathology Center of Toulouse Purpan, University of Toulouse 3, Paul Sabatier University - Physiopathology Center of Toulouse Purpan, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Physiopathology Center of Toulouse Purpan, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory and University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT)

Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), Centre de Recherche en Cancérologie de Lyon, Université Toulouse III - Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, University of Toronto - Department of Immunology, Université Toulouse III - Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Toulouse III - Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Centre de Recherche en Cancérologie de Lyon, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT) and University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT)